{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T04:09:29Z","timestamp":1749614969564,"version":"3.41.0"},"reference-count":36,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"6","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2016,12]]},"abstract":"<jats:sec><jats:title>Background:<\/jats:title><jats:p>Although azole antifungal agents have been shown to affect the pharmacokinetics of calcineurin inhibitors such as tacrolimus (TAC) and cyclosporine (CyA) by inhibiting drug metabolism, there are few clinical reports on drug interactions between miconazole (MCZ) oral gel and calcineurin inhibitors. In this study, the effects of MCZ oral gel on the blood concentrations of TAC and CyA were investigated.<\/jats:p><\/jats:sec><jats:sec><jats:title>Methods:<\/jats:title><jats:p>In this retrospective study, 18 patients concomitantly administered MCZ oral gel and TAC (9 for dermatomyositis, 3 for myasthenia gravis, 2 for systemic lupus erythematosus, 2 for rheumatoid arthritis, 1 for polymyositis, 1 for prevention of graft-versus-host disease after bone marrow transplantation), and 15 patients concomitantly administered MCZ oral gel and CyA (11 for interstitial pneumonia, 2 for pemphigus, 1 for eosinophilic granulomatosis with polyangiitis, 1 for systemic lupus erythematosus) were evaluated. The dose-adjusted blood concentrations of TAC or CyA were compared before and after the initiation of MCZ oral gel.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results:<\/jats:title><jats:p>The trough blood concentration\/dose (C\/D) ratios of TAC and CyA increased significantly with the administration of MCZ oral gel. The median C\/D ratios of TAC and CyA increased by 108% (range: \u201344% to 216%) and 44% (range: \u221234% to 195%), respectively.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions:<\/jats:title><jats:p>These results suggest that MCZ oral gel affects the pharmacokinetics of TAC and CyA. Detailed monitoring of the blood concentrations of these drugs, followed by dose adjustments, is needed for each patient because of the difficulties associated with accurately predicting the degree of the effects of MCZ oral gel.<\/jats:p><\/jats:sec>","DOI":"10.1097\/ftd.0000000000000335","type":"journal-article","created":{"date-parts":[[2016,8,24]],"date-time":"2016-08-24T16:30:25Z","timestamp":1472056225000},"page":"717-721","source":"Crossref","is-referenced-by-count":4,"title":["Effects of Miconazole Oral Gel on Blood Concentrations of Tacrolimus and Cyclosporine: A Retrospective Observational Study"],"prefix":"10.1097","volume":"38","author":[{"given":"Yasuyoshi","family":"Ishiwata","sequence":"first","affiliation":[{"name":"Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masashi","family":"Nagata","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takafumi","family":"Arai","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Misato","family":"Makiishi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maho","family":"Yoshikawa","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiromitsu","family":"Takahashi","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Medical Hospital, Tokyo Medical and Dental University (TMDU);"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hitoshi","family":"Kohsaka","sequence":"additional","affiliation":[{"name":"Rheumatology and"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masato","family":"Yasuhara","sequence":"additional","affiliation":[{"name":"Pharmacokinetics and Pharmacodynamics, Graduate School of Medical and Dental Sciences, Tokyo Medical and Dental University (TMDU), Tokyo, Japan."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-20230814","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1056\/NEJMra033540","article-title":"Immunosuppressive drugs for kidney transplantation","volume":"351","author":"Halloran","year":"2004","journal-title":"N Eng J Med."},{"key":"R2-20230814","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1007\/s12185-015-1784-2","article-title":"Prophylactic and therapeutic treatment of graft-versus-host disease in Japan","volume":"101","author":"Murata","year":"2015","journal-title":"Int J Hematol."},{"key":"R3-20230814","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ijpharm.2013.05.033","article-title":"From gut to kidney: transporting and metabolizing calcineurin-inhibitors in solid organ transplantation","volume":"452","author":"Knops","year":"2013","journal-title":"Int J Pharm."},{"key":"R4-20230814","doi-asserted-by":"crossref","first-page":"5785","DOI":"10.4049\/jimmunol.1390055","article-title":"Calcineurin inhibitors: 40 years later, can't live without\u2026","volume":"191","author":"Azzi","year":"2013","journal-title":"J Immunol."},{"key":"R5-20230814","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1016\/S0041-1345(01)02286-2","article-title":"Cyclosporine therapeutic drug monitoring","volume":"33","author":"Jensen","year":"2001","journal-title":"Transpl Proc."},{"key":"R6-20230814","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1016\/S0090-9556(25)08793-8","article-title":"Cytochrome P-450 3A enzymes are responsible for biotransformation of FK506 and rapamycin in man and rat","volume":"20","author":"Sattler","year":"1992","journal-title":"Drug Metab Dispos."},{"key":"R7-20230814","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1111\/odi.12380","article-title":"Efficacy and safety of miconazole for oral candidiasis: a systematic review and meta-analysis","volume":"22","author":"Zhang","year":"2016","journal-title":"Oral Dis."},{"key":"R8-20230814","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1248\/yakushi.125.795","article-title":"Drug-drug interaction of antifungal drugs","volume":"125","author":"Niwa","year":"2005","journal-title":"Yakugaku Zasshi."},{"key":"R9-20230814","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1124\/dmd.30.3.314","article-title":"Inhibition of cytochromes P450 antifungal imidazole derivatives","volume":"30","author":"Zhang","year":"2002","journal-title":"Drug Metab Dispos."},{"key":"R10-20230814","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/sj.bdj.4811224","article-title":"Miconazole oral gel and drug interactions","volume":"196","author":"Pemberton","year":"2004","journal-title":"Br Dent J."},{"key":"R11-20230814","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s11845-012-0862-1","article-title":"Warfarin and topical miconazole: the potential for a clinically significant interaction","volume":"182","author":"Ufondu","year":"2013","journal-title":"Ir J Med Sci."},{"key":"R12-20230814","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/j.1365-2710.2010.01229.x","article-title":"Warfarin and miconazole oral gel interactions: analysis and therapy recommendations based on clinical data and a pharmacokinetic model","volume":"36","author":"Miki","year":"2011","journal-title":"J Clin Pharm Ther."},{"key":"R13-20230814","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-008-0556-9","article-title":"Oral voriconazole and miconazole oral gel produce comparable effects on the pharmacokinetics and pharmacodynamics of etoricoxib","volume":"65","author":"Hynninen","year":"2009","journal-title":"Eur J Clin Pharmacol."},{"key":"R14-20230814","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1128\/AAC.01242-10","article-title":"Miconazole oral gel increases exposure to oral oxycodone by inhibition of CYP2D6 and CYP3A4","volume":"55","author":"Gronlund","year":"2011","journal-title":"Antimicrob Agents Chemother."},{"key":"R15-20230814","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/1759720X11419038","article-title":"The efficacy and safety of tacrolimus in rheumatoid arthritis","volume":"3","author":"Dutta","year":"2011","journal-title":"Ther Musculoskel Dis."},{"key":"R16-20230814","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/0378-4347(96)00125-9","article-title":"High-performance liquid chromatographic analysis for the determination of miconazole in human plasma using solid-phase extraction","volume":"685","author":"Kobylinska","year":"1996","journal-title":"J Chromatogr B."},{"key":"R17-20230814","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s40265-014-0316-3","article-title":"Extended-release tacrolimus: a review of its use in de novo kidney transplantation","volume":"74","author":"McCormack","year":"2014","journal-title":"Drugs"},{"key":"R18-20230814","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1093\/clinids\/15.1.17","article-title":"Primary cutaneous fungal infection after solid-organ transplantation: report of five cases and review","volume":"15","author":"Benedict","year":"1992","journal-title":"Clin Infect Dis."},{"issue":"suppl 1","key":"R19-20230814","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000239052","article-title":"Antifungal prophylaxis during neutropenia or allogeneic bone marrow transplantation: what is the state of the art? Ad HOC Working Group","volume":"38","author":"Denning","year":"1992","journal-title":"Chemother"},{"key":"R20-20230814","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1007\/s11481-006-9034-2","article-title":"MDR- and CYP3A4-mediated drug-drug interactions","volume":"1","author":"Pal","year":"2006","journal-title":"J Neuroimmune Pharmacol."},{"key":"R21-20230814","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1007\/s00228-013-1471-2","article-title":"Effect of itraconazole on the concentrations of tacrolimus and cyclosporine in the blood of patients receiving allogeneic hematopoietic stem cell transplants","volume":"69","author":"Nara","year":"2013","journal-title":"Eur J Clin Pharmacol."},{"key":"R22-20230814","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12185-009-0344-z","article-title":"Drug interaction between oral solution itraconazole and calcineurin inhibitors in allogeneic hematopoietic stem cell transplantation recipients: an association with bioavailability of oral solution itraconazole","volume":"90","author":"Mori","year":"2009","journal-title":"Int J Hematol."},{"key":"R23-20230814","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.bbmt.2005.10.022","article-title":"Pharmacokinetic evaluation of the drug interaction between intravenous itraconazole and intravenous tacrolimus or intravenous cyclosporin A in allogeneic hematopoietic stem cell transplant recipients","volume":"13","author":"Leather","year":"2006","journal-title":"Biol Blood Marrow Transpl."},{"key":"R24-20230814","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1007\/s12185-012-1057-2","article-title":"Drug interaction between voriconazole and tacrolimus and its association with the bioavailability of oral voriconazole in recipients of allogeneic hematopoietic stem cell transplantation","volume":"95","author":"Mori","year":"2012","journal-title":"Int J Hematol."},{"key":"R25-20230814","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/j.1365-2710.2009.01070.x","article-title":"Effects of voriconazole on tacrolimus metabolism in a kidney transplant recipient","volume":"35","author":"Capone","year":"2010","journal-title":"J Clin Pharm Ther."},{"key":"R26-20230814","doi-asserted-by":"crossref","first-page":"294","DOI":"10.4103\/0976-500X.119721","article-title":"Elevation of blood ciclosporin levels by voriconazole leading to leukoencephalopathy","volume":"4","author":"Qu","year":"2013","journal-title":"J Pharmacol Pharmacother."},{"key":"R27-20230814","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00228-012-1365-8","article-title":"Switching from intravenous to oral tacrolimus and voriconazole leads to a more pronounced drug-drug interaction","volume":"69","author":"Spriet","year":"2013","journal-title":"Eur J Clin Pharmacol."},{"key":"R28-20230814","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00228-007-0395-0","article-title":"Greater impact of oral fluconazole on drug interaction with intravenous calcineurin inhibitors as compared with intravenous fluconazole","volume":"64","author":"Mihara","year":"2008","journal-title":"Eur J Clin Pharmacol."},{"key":"R29-20230814","first-page":"1127","article-title":"Cyclosporine interactions with miconazole and other azole-antimycotics: a case report and review of the literature","volume":"11","author":"Horton","year":"1992","journal-title":"J Heart Lung Transpl."},{"key":"R30-20230814","first-page":"173","article-title":"Evaluation of the drug interactions between cyclosporin A and miconazole gel in interstitial pneumonia patients","volume":"50","author":"Kuromatsu","year":"2014","journal-title":"J Jpn Soc Hosp Pharm."},{"key":"R31-20230814","first-page":"2753","article-title":"Effect of temperature and hematocrit on plasma concentration of FK 506","volume":"23","author":"Machida","year":"1991","journal-title":"Transpl Proc."},{"key":"R32-20230814","first-page":"151","article-title":"Studies on the metabolic fate of miconazole (1). Absorption, distribution and excretion in rats after a single administration of miconazole","volume":"24","author":"Ohzawa","year":"1993","journal-title":"Iyakuhin Kenkyu."},{"key":"R33-20230814","first-page":"43","article-title":"Studies on the metabolic fate of miconazole (3). Absorption, distribution and metabolism after application of miconazole to oral mucosa of rats","volume":"8","author":"Ohzawa","year":"1993","journal-title":"Xenobiotic Metab Dispos."},{"key":"R34-20230814","first-page":"173","article-title":"Studies on the metabolic fate of miconazole (2). The metabolism of miconazole in rats","volume":"24","author":"Ohzawa","year":"1993","journal-title":"Iyakuhin Kenkyu."},{"key":"R35-20230814","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1211\/0022357056118","article-title":"Effect of micafungin on cytochrome P450 3A4 and multidrug resistance protein 1 activities, and its comparison with azole antifungal drugs","volume":"57","author":"Sakaeda","year":"2005","journal-title":"J Pharm Pharmacol."},{"key":"R36-20230814","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2125.1996.tb00181.x","article-title":"Identification of drugs inhibiting the in vitro metabolism of tacrolimus by human liver microsomes","volume":"41","author":"Christians","year":"1996","journal-title":"Br J Clin Pharmacol."}],"container-title":["Therapeutic Drug Monitoring"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/00007691-201612000-00011","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,6,10]],"date-time":"2025-06-10T13:32:28Z","timestamp":1749562348000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00007691-201612000-00011"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,12]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016]]}},"URL":"https:\/\/doi.org\/10.1097\/ftd.0000000000000335","relation":{},"ISSN":["0163-4356"],"issn-type":[{"type":"print","value":"0163-4356"}],"subject":[],"published":{"date-parts":[[2016,12]]}}}